News

Brief news reports on Tuberculosis

Kenya: Cases of MDRTB to rise because patients are defaulting drugs

The ministry of health has raised fears that the number of patients suffering from drug resistant TB could rise considerably because TB patients are not taking their medication.

Read More →

Prior parasitic worm infections may complicate TB therapy

Tuberculosis (TB) is a major threat to global health, taking the lives of more than a million people worldwide each year. Its greatest impact is often in the most impoverished places on earth, where patients frequently suffer from multiple chronic illnesses at the same time. In such situations, the question of whether each individual illness might make concurrent illnesses more difficult to treat becomes a critical issue both for specific patients and for general public health. New research led by Padmini Salgame, Ph.D., professor and director of the Graduate Medical Research Program at the University of Medicine and Dentistry (UMDNJ)-New Jersey Medical School, has established such a connection between tuberculosis and infection by parasitic worms, a frequent occurrence in much of the world. The study, by a team that also worked in collaboration with William C. Gause, Ph.D., professor and senior associate dean of research at New Jersey Medical School, appears in the Journal of Experimental Medicine.

Read More →

Inexpensive microcalorimeters can quickly detect TB

Researchers have discovered a faster, cheaper method for the diagnosis of tuberculosis (TB). A major barrier in TB prevention, especially in developing countries, is that diagnosis is slow and costly. Dr Olivier Braissant and his colleagues have developed a method which could potentially decrease the time taken to make a diagnosis. Their method is also cheaper than the current fastest methods. This research has been published today in the Society for Applied Microbiology's Journal of Applied Microbiology.

Read More →

SOUTH AFRICA: Lihle Dlamini, “People who have TB still face the same challenges I faced in 2002“

JOHANNESBURG, 16 August 2011 (PlusNews) - Lihle Dlamini is the deputy general-secretary of South Africa’s AIDS lobby group, the Treatment Action Campaign. As the country moves to include a strong emphasis on tuberculosis (TB) for the first time in its latest national strategic plan on HIV, Dlamini recounted her experience with TB treatment almost 10 years ago:

Read More →

Breaking the taboos of bovine TB

"I couldn't understand why I didn't feel well... I stumbled about, I generally felt very ill, I was losing weight, everything was going wrong."

Read More →

SOUTH AFRICA: Shortage of drug-resistant TB treatment looms

JOHANNESBURG, 16 August 2011 (PlusNews) - While countries are rolling out new tests that will enable them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Médecins Sans Frontières (MSF) warns.

Read More →

SOUTH AFRICA: Govt moves to earlier HIV treatment

JOHANNESBURG, 15 August 2011 (PlusNews) - HIV-positive people in South Africa will be able to access antiretrovirals (ARVs) sooner after the government raised the CD4 count necessary to access treatment. But some warn the victory is only half the battle.

Read More →

Round 11 Global Fund launch: Let's make it a TB round!

15 August 2011 - Geneva - Today is a very important day for all people committed to making tuberculosis (TB) care available to all who need it.

Read More →

Bayer donates drugs to help stamp out tuberculosis

Bayer has said it will donate 620,000 tablets of its antibiotic moxifloxacin in order to help tackle multi-drug resistant tuberculosis.

Read More →

Researchers discover key reason why pyrazinamide shortens duration of TB therapy

Pyrazinamide has been used in combination with other drugs as a first-line treatment for people with tuberculosis (TB) since the 1950s, but exactly how the drug works has not been well understood. Now, researchers have discovered a key reason why the drug effectively shortens the required duration of TB therapy. The finding potentially paves the way for the development of new drugs that can help eliminate TB in an infected individual even more rapidly. The study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and published online on August 11 in Science Express.

Read More →

Page 530 of 532 · Total posts: 10

←First 529 530 531 Last→